|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03759 PHARMARON
Nominal 
27.760 -0.880 (-3.073%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Turnover | 6,440,951 | 14.925% | 5,604,463 | 5,640,118 | 4,634,585 | 3,285,511 |
| Cost of Sales | (4,268,750) | 13.639% | (3,756,412) | (3,602,677) | (3,021,474) | (2,095,800) |
| Gross Profit | 2,172,201 | 17.540% | 1,848,051 | 2,037,441 | 1,613,111 | 1,189,711 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (37,143) | 61.914% | (22,940) | (10,713) | (6,339) | 472 | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (32,657) | 7.758% | (30,306) | 10,982 | (4,439) | (6,993) | |
| Profit / (Loss) before Taxation | 812,756 | -33.753% | 1,226,851 | 908,525 | 742,698 | 665,910 | |
| Taxation | (160,126) | 11.272% | (143,905) | (124,457) | (177,398) | (118,610) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 48,766 | 60.114% | 30,457 | 2,025 | 20,132 | 17,537 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 701,396 | -37.004% | 1,113,403 | 786,093 | 585,432 | 564,837 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/06 RMB(K¥) | 2023/06 RMB(K¥) | 2022/06 RMB(K¥) | 2021/06 RMB(K¥) | |
| Net Finance Costs / (Income) | 76,709 | -12.205% | 87,373 | 74,792 | 57,933 | (4,098) |
| Depreciation & Amortisation | 609,426 | 9.843% | 554,813 | 481,689 | 340,423 | 269,291 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/06 | 2023/06 | 2022/06 | 2021/06 | |
| EPS (cts) | 39.840 | -36.581% | 62.820 | 44.420 | 32.940 | 31.673 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 8.056 | -- | 7.280 | 6.345 | 5.573 | 5.240457 |
| Remarks: | Real time quote last updated: 18/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 701,396 |
| %Change | -37.004% |
| EPS / (LPS) | RMB 0.398 |
| NBV Per Share (¥) | RMB 8.056 |